These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1793867)

  • 1. [Increase of the production of tumor necrosis factor in endotoxin shock in mice presensitized with sera of tumor-bearing mice or tumor cell factor].
    Fuks BB; Shapoval AI; Grzhebin IM I
    Biull Eksp Biol Med; 1991 Jul; 112(7):78-80. PubMed ID: 1793867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of tumor necrosis factor in lethality during endotoxic shock in mice presensitized with serum of tumor-bearing mice].
    Shapoval AI
    Biull Eksp Biol Med; 1993 Jan; 115(1):57-9. PubMed ID: 8054581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro].
    Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV
    Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
    Shimizu T; Iwamoto Y; Yanagihara Y; Ikeda K; Achiwa K
    Int J Immunopharmacol; 1992 Nov; 14(8):1415-20. PubMed ID: 1464473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes.
    Kawa K; Tsutsui H; Uchiyama R; Kato J; Matsui K; Iwakura Y; Matsumoto T; Nakanishi K
    Int Immunol; 2010 Mar; 22(3):157-66. PubMed ID: 20130231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of experimental septic shock by pretreatment of mice with muramyl peptides.
    Meshcheryakova E; Guryanova S; Makarov E; Alekseeva L; Andronova T; Ivanov V
    Int Immunopharmacol; 2001 Sep; 1(9-10):1857-65. PubMed ID: 11562077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of cellular immunity in mice under normal conditions and in tumor growth during treatment with glucosaminyl muramyl dipeptide].
    Pimenov AA; Rakhmilevich AL; Deev VV; Kirillova IV; Migdal TL; Andronova TM; Fuks BB
    Vopr Med Khim; 1990; 36(1):58-60. PubMed ID: 2343578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GMDP augments antitumor action of the CP/TNFalpha combination in vivo.
    Petrova EE; Simonova MA; Komaleva RL; Britsina MV; Andronova TM; Nesmeyanov VA; Valyakina TI
    Biomed Pharmacother; 2010 Apr; 64(4):240-8. PubMed ID: 19932583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous tumour necrosis factor-alpha sensitise melanoma cells to glucosaminylmuramyl dipeptide.
    Valyakina TI; Komaleva RL; Petrova EE; Malakhov AA; Shamborant OG; Andronova TM; Nesmeyanov VA
    FEBS Lett; 1998 Apr; 426(3):373-6. PubMed ID: 9600269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of endotoxin shock and endotoxin hypersensitivity.
    Galanos C; Freudenberg MA
    Immunobiology; 1993 Apr; 187(3-5):346-56. PubMed ID: 8330903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulation of tumour necrosis factor-alpha, interleukin-1 alpha and glucose levels with GMDP and other analogues of muramyl dipeptide.
    Adeleye TA; Moreno C; Ivanyi J; Aston R
    APMIS; 1994 Feb; 102(2):145-52. PubMed ID: 8167010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.
    Murakami T; Obata T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
    Int Immunol; 2009 Aug; 21(8):905-12. PubMed ID: 19556302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of liposomal glucosaminyl-muramyl dipeptide on superoxide and nitric oxide production by murine macrophages].
    Parshykov OV; Stefanov OV
    Ukr Biokhim Zh (1999); 2009; 81(5):74-82. PubMed ID: 20387650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
    Hornung RL; Longo DL; Gowda VL; Kwak LW
    Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells.
    Petrova EE; Valyakina TI; Simonova MA; Komaleva RL; Khaidukov SV; Makarov EA; Blokhin DY; Ivanov PK; Andronova TM; Nesmeyanov VA
    Int Immunopharmacol; 2006 Sep; 6(9):1377-86. PubMed ID: 16846831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin.
    Hsueh W; Sun X; Rioja LN; Gonzalez-Crussi F
    Immunology; 1990 Jul; 70(3):309-14. PubMed ID: 2379939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
    Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunostimulating properties of synthetic derivatives of muramyl dipeptide and glucosaminyl muramyl dipeptide in vitro].
    Rakhmilevich AL; Migdal TL; Rakhimova MS; Shneĭderova MA; Chirva VIa; Zemliakov AE
    Antibiot Khimioter; 1989 Nov; 34(11):836-9. PubMed ID: 2633699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of systemic TNF-alpha cytotoxicity in cancer patients by D-peptidoglycan.
    Slesarev VI; Ellithorpe R; Dimitroff T
    Med Oncol; 1998 Apr; 15(1):37-43. PubMed ID: 9643529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.